| Literature DB >> 30008192 |
Ungsoo Samuel Kim1,2, Neringa Jurkute3, Patrick Yu-Wai-Man3,4,5,6.
Abstract
Leber hereditary optic neuropathy (LHON) is an important cause of mitochondrial blindness. The majority of patients harbor one of three mitochondrial DNA (mtDNA) point mutations, m.3460G>A, m.11778G>A, and m.14484T>C, which all affect complex I subunits of the mitochondrial respiratory chain. The loss of retinal ganglion cells in LHON is thought to arise from a combination of impaired mitochondrial oxidative phosphorylation resulting in decreased adenosine triphosphate (ATP) production and increased levels of reactive oxygen species. Treatment options for LHON remain limited, but major advances in mitochondrial neuroprotection, gene therapy, and the prevention of transmission of pathogenic mtDNA mutations will hopefully translate into tangible benefits for patients affected by this condition and their families. Copyright 2018 Asia-Pacific Academy of Ophthalmology.Entities:
Keywords: LHON; Leber hereditary optic neuropathy; gene therapy; idebenone; mitochondrial donation; neuroprotection; retinal ganglion cells
Mesh:
Substances:
Year: 2018 PMID: 30008192 DOI: 10.22608/APO.2018293
Source DB: PubMed Journal: Asia Pac J Ophthalmol (Phila) ISSN: 2162-0989